Valganciclovir Hydrochloride For Solution
Product Images NDC 72205-019

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Valganciclovir Hydrochloride (NDC 72205-019). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Valganciclovir-50mg-100ml-cntr-label (Valganciclovir 50mg 100ml Cntr Label)

Valganciclovir for oral solution is a prescription drug that contains 50 mg/ml of valganciclovir free base. It is used as per the instructions provided in the package insert. The dry powder should be stored at 68°F to 77°F. While storing the constituted solution, it should be kept under refrigeration at 36°F to 46°F. The constituted oral solution can be used within 49 days of preparation after writing the discard date on the bottle label. It is distributed by Novadoz Pharmaceuticals LLC and manufactured by MSN Pharmaceuticals Inc.*

FDA Label Image

Valganciclovir-50mg-100ml-crtn-label (Valganciclovir 50mg 100ml Crtn Label)

Valganciclovir for Oral Solution is a medicine that comes in a dry powder form and requires water to be added before use. After the powder is mixed with purified water, each mL of the oral solution contains 50 mg valganciclovir free base. The solution should not be stored beyond 49 days post-preparation and should be kept in its original bottle under refrigeration until use. The medicine should not be frozen, and any unused portions should be discarded. The box contains one bottle of 12 dry powder units, one adapter, and two oral dispensers. The accompanying patient instructions comprise important prescribing and handling information.*

FDA Label Image

Valganciclovir-dose-calculation-formula (Valganciclovir Dose Calculation Formula)

FDA Label Image

Valganciclovir-fig-1 (Valganciclovir Fig 1)

The text appears to be a diagram or illustration of a child-resistant cap bottle with an adapter and an oral dispenser with a plunger. There is not enough information available to provide a more detailed description.*

FDA Label Image

Valganciclovir-fig-10 (Valganciclovir Fig 10)

FDA Label Image

Valganciclovir-fig-11 (Valganciclovir Fig 11)

FDA Label Image

Valganciclovir-fig-12 (Valganciclovir Fig 12)

FDA Label Image

Valganciclovir-fig-2 (Valganciclovir Fig 2)

FDA Label Image

Valganciclovir-fig-3 (Valganciclovir Fig 3)

FDA Label Image

Valganciclovir-fig-4 (Valganciclovir Fig 4)

FDA Label Image

Valganciclovir-fig-5 (Valganciclovir Fig 5)

FDA Label Image

Valganciclovir-fig-6 (Valganciclovir Fig 6)

FDA Label Image

Valganciclovir-fig-7 (Valganciclovir Fig 7)

FDA Label Image

Valganciclovir-fig-8 (Valganciclovir Fig 8)

FDA Label Image

Valganciclovir-formula (Valganciclovir Formula)

This formula is used to estimate glomerular filtration rate (GFR), a measure of kidney function, in males. The formula considers age, body weight, and serum creatinine levels.*

FDA Label Image

Valganciclovir-structural-formula (Valganciclovir Structural Formula)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.